Polar Capital Holdings’s Adicet Bio ACET Stock Holding History

Polar Capital Holdings’s Portfolio ACET Stock Details ACET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-78,989	Closed	-$7.28M	–	288
2023 Q1	$7.28M	Hold	78,989	–	–	0.05%	212
2022 Q4	$11.3M	Sell	78,989 -1,865	-2%	-$465K	0.09%	185
2022 Q3	$18.4M	Sell	80,854 -15,625	-16%	-$3.97M	0.12%	150
2022 Q2	$22.5M	Hold	96,479	–	–	0.13%	134
2022 Q1	$30.8M	Buy	96,479 +1,024	+1%	+$236K	0.14%	130
2021 Q4	$26.7M	Buy	+95,455	New	+$16.4M	0.1%	148

Other funds holding ACET

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Polar Capital Holdings's ACET Position: Q2 2023 in Review

Polar Capital Holdings sold out of Adicet Bio (ACET) in Q2 2023, closing a stake of 78,989 shares — an estimated $7.28M sold.

Polar Capital Holdings first reported a position in ACET in Q4 2021 and held it in 6 quarters. The position peaked at $30.8M in Q1 2022. 94 funds tracked by Wall St. Rank hold ACET as of Q2 2023.

Polar Capital Holdings reported no remaining Adicet Bio position as of Q2 2023 after selling out during the quarter.
Polar Capital Holdings sold 78,989 Adicet Bio shares in Q2 2023, an estimated $7.28M.
Polar Capital Holdings first reported a position in Adicet Bio in Q4 2021 and held it in 6 quarters.
Polar Capital Holdings's Adicet Bio position peaked at $30.8M in Q1 2022.
94 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2023.

Based on Polar Capital Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.